ABT US0028241000

Report

Delayed Nyse - 12/03 04:10:00 pm
130.27	USD		+1.47%

12/03	Health Care Ticks Lower As Pfizer Gains - Health Care Roundup	DJ
11/29	Thermo Fisher says its COVID-19 tests accurately detects Omicron variant	RE
11/18	INSIDER SELL : Abbott Laboratories	MT

Summary

Quotes 5-day view Delayed Quote.

Delayed Nyse

11/29/2021	11/30/2021	12/01/2021	12/02/2021	12/03/2021	Date
128.03(c)	125.77(c)	126.74(c)	128.38(c)	130.27(c)	Last
5 648 325	7 270 172	4 816 874	5 090 982	5 129 379	Volume
+1.71%	-1.77%	+0.77%	+1.29%	+1.47%	Change

More quotes

Estimated financial data (e) (USD)

Sales 2021	42 030 M - -
Net income 2021	6 560 M - -
Net Debt 2021	8 142 M - -
P/E ratio 2021	35,2x
Yield 2021	1,30%

Sales 2022	39 927 M - -
Net income 2022	6 544 M - -
Net Debt 2022	3 661 M - -
P/E ratio 2022	36,1x
Yield 2022	1,35%

Capitalization	230 B 230 B -
EV / Sales 2021	5,67x
EV / Sales 2022	5,86x
Nbr of Employees	109 000
Free-Float	88,5%

More Financials

Company

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products,...

Sector

Medical Equipment, Supplies & Distribution

Calendar

01/26

Earnings Release

More about the company

Ratings of Abbott Laboratories

Trading Rating :

Investor Rating :

ESG Refinitiv :

B-

More Ratings

All news about ABBOTT LABORATORIES

12/03	Health Care Ticks Lower As Pfizer Gains - Health Care Roundup	DJ
11/29	Thermo Fisher says its COVID-19 tests accurately detects Omicron variant	RE
11/18	INSIDER SELL : Abbott Laboratories	MT
11/17	Abbott launches similac 360 total care with exclusive blend of five hmo prebiotics and ..	AQ
11/16	Abbott Laboratories Launches Similac 360 Total Care Infant Formula	MT
11/16	Abbott Launches Similac® 360 Total Care® with Exclusive Blend of Five HMO Prebiotics an..	PR
11/16	Abbott Launches Similac? 360 Total Care? with Exclusive Blend of Five Hmo Prebiotics an..	CI
11/16	Talis Biomedical Names Brian Blaser Chief Executive	MT
11/15	Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow..	PR
11/15	Abbott's new leadless pacemaker system meets primary endpoints in pivotal trial	AQ
11/12	Abbott Laboratories Says its New Leadless Pacemaker Meets Safety, Efficacy Endpoints	MT
11/12	Abbott Laboratories New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Tr..	CI
11/09	Abbott and the American Diabetes Association? Launch First-of-Its-Kind Community Initia..	CI
11/04	Abbott launches new initiative to drive diversity in medical research and improve care ..	AQ
11/03	ABBOTT LABORATORIES Management's Discussion and Analysis of Financial Condition and Re..	AQ

More news

News in other languages on ABBOTT LABORATORIES

11/18	VENTE D'INITIÉS : Abbott Laboratories
11/16	Les Laboratoires Abbott lancent la préparation pour nourrissons Similac 360 Total Care
11/16	Talis Biomedical nomme Brian Blaser au poste de directeur général
11/12	Les Laboratoires Abbott affirment que leur nouveau stimulateur cardiaque sans fil répon..
11/03	OPINIONES DE LOS ANALISTAS DEL DÍA : BMW ,BBVA, Roche, Hellofresh, chegg, Linde, ABB, Unde..

More news

Analyst Recommendations on ABBOTT LABORATORIES

10/27	ANALYST RECOMMENDATIONS : Alphabet, Apple, AppLovin, Gnereal Electric, Microsoft, Tesla...
10/27	Atlantic Equities Upgrades Abbott Laboratories to Overweight From Neutral; Price Target..	MT
10/21	ABBOTT LABORATORIES : UBS Adjusts Price Target on Abbott Laboratories to $138 From $131, M..	MT

More recommendations

Stock Trading Strategies

	ABBOTT LABORATORIES - 01/20
Close to a key resistance level

BUY

More Stock Trading Analysis

Provided by Scoopnest.com

Analysis

Thermo Fisher set to benefit from demand for testing kits, vaccines